vTv Therapeutics Inc.
VTVT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1 | $0 | $2 | $4 |
| % Growth | – | -100% | -49.6% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $1 | $0 | $2 | $4 |
| % Margin | 100% | – | 100% | 100% |
| R&D Expenses | $12 | $14 | $12 | $13 |
| G&A Expenses | $14 | $12 | $12 | $12 |
| SG&A Expenses | $14 | $12 | $12 | $12 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $25 | $26 | $25 | $26 |
| Operating Income | -$24 | -$26 | -$23 | -$22 |
| % Margin | -2,377.6% | – | -1,116.9% | -540.9% |
| Other Income/Exp. Net | $2 | -$0 | -$2 | $4 |
| Pre-Tax Income | -$23 | -$26 | -$25 | -$18 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$18 | -$20 | -$19 | -$13 |
| % Margin | -1,815.3% | – | -949.7% | -324.3% |
| EPS | -3.2 | -9.71 | -9.98 | -8.29 |
| % Growth | 67% | 2.7% | -20.4% | – |
| EPS Diluted | -3.2 | -9.71 | -9.98 | -8.29 |
| Weighted Avg Shares Out | 6 | 2 | 2 | 2 |
| Weighted Avg Shares Out Dil | 6 | 2 | 2 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$23 | -$26 | -$25 | -$18 |
| % Margin | -2,214% | – | -1,227.3% | -437.3% |